SLRX
Salarius Pharmaceuticals Inc
NASDAQ: SLRX · HEALTHCARE · BIOTECHNOLOGY
$0.84
+29.23% today
Updated 2026-01-07
Market cap
$4.92M
P/E ratio
—
P/S ratio
18.12x
EPS (TTM)
$-24.24
Dividend yield
—
52W range
$1 – $25
Volume
2.4M
Salarius Pharmaceuticals Inc (SLRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.75M | $-32.05M | $-27.72M | $-23.60M | $-11.58M | $-10.31M | $-10.20M | $-17.60M | $-12.85M | $-4.53M |
| Capital expenditures | $265617.00 | $559378.00 | $113498.00 | $2600.00 | $2600.00 | $2600.00 | $3.00 | $1.50M | $3.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — |
| Free cash flow | $-21.01M | $-32.61M | $-27.84M | $-23.60M | $-11.58M | $-10.31M | $-10.20M | $-19.10M | $-12.85M | $-4.53M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $133594.00 | $133594.00 | $133594.00 | $133594.00 | $0.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | $32.83M | — | — | — | $-2.39M | $7.38M | — | — | — | — |